Hypertension and Diabetes Mellitus
Authors:
- Maryann N. MugoMMMaryann N. Mugo
- Craig S. StumpCSCraig S. Stump
- Priya G. RaoPRPriya G. Rao
- James R. SowersJSJames R. Sowers
Open Access
- 1 January 2007
- book chapter
- Published by Elsevier
- p. 406-417
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- Renin-angiotensin system inhibition prevents type 2 diabetes mellitusDiabetes & Metabolism, 2004
- Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trialsAmerican Heart Journal, 2004
- When Does New Onset Diabetes Resulting From Antihypertensive Therapy Increase Cardiovascular RiskHypertension, 2004
- Adverse Prognostic Significance of New Diabetes in Treated Hypertensive SubjectsHypertension, 2004
- Relationship of Physical Activity and Body Mass Index to the Risk of Hypertension: A Prospective Study in FinlandHypertension, 2004
- Diabetes, Hypertension, and Cardiovascular DiseaseHypertension, 2001
- Baseline Characteristics and Early Blood Pressure Control in the CONVINCE TrialHypertension, 2001
- Insulin and Insulin-Like Growth Factor in Normal and Pathological Cardiovascular PhysiologyHypertension, 1997
- Insulin resistance and hypertensionMolecular and Cellular Endocrinology, 1990